Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study

Objective: The upcoming introduction of mepolizumab represents a promising treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The present study aimed to evaluate the effectiveness of mepolizumab on sinonasal outcomes of comorbid CRSwNP and severe asthma in a real-life setting. The prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Stefania, Castelnuovo, Paolo, Spirito, Luca, Feduzi, Marta, Seccia, Veronica, Visca, Dina, Spanevello, Antonio, Statuti, Erica, Latorre, Manuela, Montuori, Claudio, Rizzi, Angela, Boccabella, Cristina, Bonini, Matteo, De Corso, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409669/
https://www.ncbi.nlm.nih.gov/pubmed/36013253
http://dx.doi.org/10.3390/jpm12081304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409669/
https://www.ncbi.nlm.nih.gov/pubmed/36013253
http://dx.doi.org/10.3390/jpm12081304

Ejemplares similares